WuXi Biologics (Cayman) Inc 2025 Annual Report
Company: WuXi Biologics (Cayman) Inc
Sector: Professional & technical services
Country: China
Year: 2025
Type: Annual Report
Pages: 263
The report presents the Group's 2025 performance, including consolidated revenue of RMB21,790,018 thousand, 16.7% growth, and 209 new integrated projects bringing total projects to 945. It reports a year-end workforce of 13,252 employees and a board gender ratio of 33.33% female. Sustainability disclosures describe UNGC participation, SBTi-validated near-term and net-zero targets, ISO 20400 certification, and ESG oversight through a dedicated committee.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.